01 September 1997
Antimicrobial susceptibility of common bacterial pathogens isolated from lower respiratory tract infections in Poland in 1996 - the Alexander Project
Krzysztof Trzciński, Waleria Hryniewicz, The Alexander Project Collaborative GroupMed Sci Monit 1997; 3(5): EP714-722 :: ID: 501672
Abstract
In 1996, the Alexander Project, an international multi-centre study on the antimicrobial susceptibility of bacterial pathogens isolated from community-acquired lower respiratory tract infections (LRTI) commenced in Poland. Altogether 506 bacterial isolates were collected from sputum, broncho-alveolar and blood samples taken from patients diagnosed with LRTI. Of these, 262 were identified as Haemophilus influenzae (51.8% of all isolates), 154 as Streptococcus pneumoniae (30.4%), 60 as Moraxella catarrhalis (11.9%) and 30 as Staphylococcus aureus (5.9%). All strains were analysed according to their susceptibility to a wide set of antimicrobial agents by the broth microdilution method. Ten H. influenzae strains (3.8%) were identified as ampicillin-resistant, beta-lactamase-positive. In 6 other isolates (2.3%) lowered susceptibility to ampicillin without beta-lactamase production was detected, which may be indicate that these are ampicillin-resistant, beta-lactamase-negative (BLNAR) H. influenzae. Twenty two Streptococcus pneumoniae isolates (14.3%) were identified as penicillin non-susceptible pneumococci (PNSP). In this group of pneumococcal isolates, multi-drug resistance was observed. Among PNSP, only 18.2% were susceptible to doxycycline, 27.3% to co-trimoxazole, 36.4% to erythromycin, and 68.8% to chloramphenicol. Twelve (7.8%) PNSP isolates have been identified as intermediately susceptible to penicillin (MIC ranging from 0.12 to 1 mg/l) and all were susceptible to amoxicillin. Over 80% of M. catarrhalis and S. aureus isolates were beta-lactamase positive. Of the antimicrobial agents analysed over 90% of isolates were identified as being susceptible to ceftriaxone, amoxicillin with clavulanic acid, cefuroxime, ciprofloxacin and ofloxacin.
The Alexander Project is organised and funded by SmithKline Beecham.
Keywords: Alexander Project, lower respiratory tract infections, antibiotic resistance
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952